Yousif Capital Management LLC Cuts Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Yousif Capital Management LLC decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 22,778 shares of the company’s stock after selling 2,375 shares during the period. Yousif Capital Management LLC’s holdings in Henry Schein were worth $1,725,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Xponance Inc. increased its holdings in Henry Schein by 2.1% during the 3rd quarter. Xponance Inc. now owns 21,839 shares of the company’s stock worth $1,622,000 after purchasing an additional 443 shares during the period. Everett Harris & Co. CA increased its holdings in Henry Schein by 29.1% during the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock worth $7,925,000 after purchasing an additional 23,622 shares during the period. Duality Advisers LP acquired a new position in shares of Henry Schein during the 4th quarter worth about $1,561,000. Sprucegrove Investment Management Ltd. boosted its position in shares of Henry Schein by 14.2% during the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after acquiring an additional 27,500 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Henry Schein by 215.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 74,251 shares of the company’s stock worth $5,622,000 after acquiring an additional 50,723 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Jefferies Financial Group upped their price objective on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. SVB Leerink assumed coverage on Henry Schein in a research report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. Finally, Piper Sandler upped their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and an average price target of $81.09.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Stock Down 0.7 %

Shares of NASDAQ HSIC opened at $68.78 on Thursday. The stock has a market cap of $8.84 billion, a PE ratio of 21.83, a price-to-earnings-growth ratio of 1.81 and a beta of 0.87. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The business has a 50-day moving average price of $73.87 and a 200 day moving average price of $72.36.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same period in the previous year, the business posted $1.21 earnings per share. The firm’s revenue was down 10.5% compared to the same quarter last year. Equities research analysts forecast that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.